Quantum Biopharma Ltd.

Over the past 90 days, Quantum Biopharma Ltd. (QNTM) has generated zero cyber incidents and zero red-flag 8-K filings, suggesting operational stability in the near term. However, absence of recent events does not indicate absence of risk; the filing window captures only three months, and biotech companies face structural pressures across longer timeframes. The full $49 Report extends analysis to 12 months of filings, quantifies dilution risk from equity raises, maps the complete financing history, and surfaces AI-detected signals across SEC documents. The full $49 Report adds comprehensive dilution scoring, 8-K context over a full year, financing trajectory analysis, and early-stage risk signals you won't find in headlines.